Literature DB >> 11097150

Survival of women with breast cancer in relation to smoking.

J Manjer1, I Andersson, G Berglund, L Bondesson, J P Garne, L Janzon, J Malina, S Matson.   

Abstract

OBJECTIVE: To compare survival of patients with breast cancer who had never smoked, were smokers, and who were ex-smokers.
DESIGN: Observational study.
SETTING: City of Malmö, Sweden. PATIENTS: 792 patients with breast cancer diagnosed between 1977-1986 in the Malmö mammographic screening trial.
INTERVENTIONS: Follow-up of breast cancer cases through record-linkage with the Swedish Cause of Death Registry. MAIN OUTCOME MEASURES: Death from breast cancer. Relative risk (RR) with 95% confidence interval (CI) of death from breast cancer was calculated for different smoking groups using Cox's proportional hazards analysis.
RESULTS: During a mean follow-up of 12.1 years, 145 patients died of breast cancer. Breast cancer mortality was 1347/10(5) person-years in those who had never smoked, 1941/10(5) in smokers, and 1493/10(5) in ex-smokers. The crude RR for smokers and ex-smokers, compared with those who had never smoked were 1.44 (1.01 to 2.06) and 1.13 (0.66 to 1.94), respectively. The RR associated with smoking remained significant after adjustment for age and stage at diagnosis, 2.14 (1.47 to 3.10), and other potential confounders.
CONCLUSIONS: Survival after breast cancer was, as expected, strongly related to stage at diagnosis. However, stage by stage there was considerable variation between individual patients. We conclude that differences with regard to exposure to smoking contribute to this heterogeneity.

Entities:  

Mesh:

Year:  2000        PMID: 11097150     DOI: 10.1080/110241500447227

Source DB:  PubMed          Journal:  Eur J Surg        ISSN: 1102-4151


  24 in total

1.  Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.

Authors: 
Journal:  Breast Cancer Res Treat       Date:  2007-10-31       Impact factor: 4.872

2.  Lifetime cigarette smoking and breast cancer prognosis in the After Breast Cancer Pooling Project.

Authors:  John P Pierce; Ruth E Patterson; Carolyn M Senger; Shirley W Flatt; Bette J Caan; Loki Natarajan; Sarah J Nechuta; Elizabeth M Poole; Xiao-Ou Shu; Wendy Y Chen
Journal:  J Natl Cancer Inst       Date:  2013-12-07       Impact factor: 13.506

Review 3.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

4.  Benzo-[a]-pyrene increases invasion in MDA-MB-231 breast cancer cells via increased COX-II expression and prostaglandin E2 (PGE2) output.

Authors:  M E Miller; A C Holloway; W G Foster
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 5.  Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.

Authors:  Dejana Braithwaite; Monika Izano; Dan H Moore; Marilyn L Kwan; Martin C Tammemagi; Robert A Hiatt; Karla Kerlikowske; Candyce H Kroenke; Carol Sweeney; Laurel Habel; Adrienne Castillo; Erin Weltzien; Bette Caan
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

6.  Active smoking and survival following breast cancer among African American and non-African American women in the Carolina Breast Cancer Study.

Authors:  Humberto Parada; Xuezheng Sun; Chiu-Kit Tse; Andrew F Olshan; Melissa A Troester; Kathleen Conway
Journal:  Cancer Causes Control       Date:  2017-07-10       Impact factor: 2.506

7.  Disparities in smoking and cessation status among cancer survivors and non-cancer individuals: a population-based study from National Health and Nutrition Examination Survey.

Authors:  Tung-Sung Tseng; Hui-Yi Lin; Michelle Y Martin; Ted Chen; Edward E Partridge
Journal:  J Cancer Surviv       Date:  2010-05-13       Impact factor: 4.442

8.  Active and passive cigarette smoking and mortality among Hispanic and non-Hispanic white women diagnosed with invasive breast cancer.

Authors:  Stephanie D Boone; Kathy B Baumgartner; Richard N Baumgartner; Avonne E Connor; Esther M John; Anna R Giuliano; Lisa M Hines; Shesh N Rai; Elizabeth C Riley; Christina M Pinkston; Roger K Wolff; Martha L Slattery
Journal:  Ann Epidemiol       Date:  2015-08-28       Impact factor: 3.797

9.  Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer.

Authors:  Sharon K Sagiv; Mia M Gaudet; Sybil M Eng; Page E Abrahamson; Sumitra Shantakumar; Susan L Teitelbaum; Paula Bell; Joyce A Thomas; Alfred I Neugut; Regina M Santella; Marilie D Gammon
Journal:  Environ Res       Date:  2009-01-31       Impact factor: 6.498

10.  Correlates of circulating C-reactive protein and serum amyloid A concentrations in breast cancer survivors.

Authors:  Brandon L Pierce; Marian L Neuhouser; Mark H Wener; Leslie Bernstein; Richard N Baumgartner; Rachel Ballard-Barbash; Frank D Gilliland; Kathy B Baumgartner; Bess Sorensen; Anne McTiernan; Cornelia M Ulrich
Journal:  Breast Cancer Res Treat       Date:  2008-04-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.